Subjective responses to pharmacological treatments in bipolar patients

Journal of Affective Disorders

Volumn 77, Issue 2, 2003, Pages 191-192

  Strejilevich, Sergio ^a   Garcia Bonetto, Gerardo ^a  

^a Hosp Gen Agudos Parmenio T Pinero   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; TRIFLUOPERAZINE; VALPROATE SEMISODIUM;

ARGENTINA; BIPOLAR DISORDER; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EXPERIENCE; HEALTH CARE FACILITY; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 0242266528     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00111-8     Document Type: Article

References (5)

1. Awad A.G., Hogan T.P. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr Scand. 89:(Suppl 380):1994;27-32.
2. Brotman M.A., Fergus E.L., Post R.M., Leverich G.S. High exposure to neuroleptics in bipolar patients: a retrospective review. J Clin Psychiatry. 61:(1):2000;68-72.
3. Moore A., Sellwood W., Stirling J. Compliance and psychological reactance in schizophrenia. Br J Clin Psychol. 39:(Pt 3):2000;287-295.
4. Sernyak M.J., Godleski L.S., Griffin R.A., et al. Chronic neuroleptic exposure in bipolar outpatients. J Clin Psychiatry. 58:1997;193-195.
5. Strejilevich S., García Bonetto G., Chan M., et al. Problemas actuales respecto del diagnóstico y tratamiento del trastorno bipolar en nuestro medio: experiencia y opinión de los usuarios. Pren. Méd. Argent. 86:1999;823-830.